A clinical trial to study the effect of a Under eye Skin cream containing Biophytex LS 8740 and Proteasyl TP LS 8657 in patients with under eye dark circles.
- Conditions
- Health Condition 1: null- Under eye dark circles (Infra orbital hyperchromia)
- Registration Number
- CTRI/2010/091/001346
- Lead Sponsor
- Glenmark Pharmaceutical limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 500
Subjects eligible for enrolment in the study must meet all the following criteria.
Subjects with mild, moderate or severe under eye dark circles
Subjects must be 18-50 years of age
Subjects must provide written informed consent and comply to the protocol
Subjects meeting any of the following criteria must not be enrolled in the clinical study.
Subjects not willing to discontinue all topical treatments for ?Under Eye? dark circles for 2 weeks prior to enrollment in study
Hypersensitivity to any ingredients of Wunder Eye cream
Pregnant and lactating women
Subjects taking Concomitant therapy* that might interfere with the study results
Subjects with dermatological disorder of face that may interfere with study evaluation
Subjects who have undergone any surgical treatment of the face
*Concomitant topical therapy in under eye area that causes hypopigmentation, includes Retinoids and Hyroquinone skin peels.
*Concomitant medicines, that causes hyper pigmentation, includes Phenothiazines, Anti-malarials (Chloroquine), Phenytoin sodium, Cytotoxic drugs, Sulphonamides.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method